Hiroki Yoshida

19.7k total citations · 7 hit papers
278 papers, 16.1k citations indexed

About

Hiroki Yoshida is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Hiroki Yoshida has authored 278 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Immunology, 70 papers in Molecular Biology and 44 papers in Surgery. Recurrent topics in Hiroki Yoshida's work include Immune Cell Function and Interaction (29 papers), T-cell and B-cell Immunology (26 papers) and Psoriasis: Treatment and Pathogenesis (20 papers). Hiroki Yoshida is often cited by papers focused on Immune Cell Function and Interaction (29 papers), T-cell and B-cell Immunology (26 papers) and Psoriasis: Treatment and Pathogenesis (20 papers). Hiroki Yoshida collaborates with scholars based in Japan, United States and Canada. Hiroki Yoshida's co-authors include Tak W. Mak, Hiroshi Nishina, Yoshiyuki Miyazaki, Shinjiro Hamano, Christopher A. Hunter, Erwin F. Wagner, Andrew Wakeham, Tadatsugu Taniguchi, Jun‐ichiro Inoue and Hiroshi Takayanagi and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Hiroki Yoshida

270 papers receiving 15.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

2002 2.2k citations Hiroki Yoshida, Tak W. Mak et al. profile →
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death

2001 1.1k citations Hiroki Yoshida et al. profile →
Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.

1998 752 citations Hiroki Yoshida et al. PubMed profile →
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

2005 731 citations Hiroki Yoshida, Tak W. Mak et al. profile →
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition

1999 559 citations Hiroki Yoshida, Tak W. Mak et al. profile →
Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum

1998 517 citations Hiroki Yoshida, Tak W. Mak et al. profile →
Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

2017 414 citations Hiroki Yoshida et al. profile →

Peers

Countries citing papers authored by Hiroki Yoshida

Since Specialization

Citations

This map shows the geographic impact of Hiroki Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Yoshida more than expected).

Fields of papers citing papers by Hiroki Yoshida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Yoshida. The network helps show where Hiroki Yoshida may publish in the future.

Co-authorship network of co-authors of Hiroki Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Yoshida. A scholar is included among the top collaborators of Hiroki Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Yoshida. Hiroki Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interleukin-27 deletion has neuroprotective effects in the acute ischemic stage of cerebral infarction 2025 ·Biochemical and Biophysical Research Communications ·Takashi Furukawa, Yasunobu Miyake, (unknown), (unknown), (unknown), Yukiko Nakahara, Fumitaka Yoshioka, Jun Masuoka, Hiroki Yoshida, Tatsuya Abe	4
2	Regulation of memory CD4+ T-cell generation by intrinsic and extrinsic IL-27 signaling during malaria infection 2024 ·International Immunology ·(unknown), Shinichi Inoue, (unknown), (unknown), Daisuke Kimura, Mana Miyakoda, Masahiro Yamamoto, Hiromitsu Hara, Hiroki Yoshida, Katsuyuki Yui	1
3	Links between cholesteryl sulfate-dependent and -independent processes in the morphological and physiological changes of Entamoeba encystation 2023 ·Parasitology International ·Fumika Mi‐ichi, Shinjiro Hamano, Hiroki Yoshida	0
4	TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation 2021 ·Nature Communications ·Ei’ichi Iizasa, (unknown), Takayuki Uematsu, (unknown), Hiroaki Kawaguchi, Masayuki Umemura, Kenji Toyonaga, (unknown), Ikuya Yano, Marco Colonna, Masahiko Sugita, Goro Matsuzaki, Sho Yamasaki, Hiroki Yoshida, Hiromitsu Hara	55
5	Apoptosis is involved in maintaining the character of the midbrain and the diencephalon roof plate after neural tube closure 2020 ·Developmental Biology ·(unknown), Yoshifumi Yamaguchi, (unknown), Keiko Nonomura, Yukiko Muramatsu, Hiroki Yoshida, Masayuki Miura	2
6	Adjuvant activity of Mycobacteria-derived mycolic acids 2020 ·Heliyon ·(unknown), Ei’ichi Iizasa, (unknown), (unknown), Hiromitsu Hara, Hiroki Yoshida	10
7	Top-Down Processing in Four-skills Integrated Computer-Assisted Language Learning 2018 ·Hiroki Yoshida, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
8	Apaf1 plays a negative regulatory role in T cell responses by suppressing activation of antigen-stimulated T cells 2018 ·PLoS ONE ·(unknown), Yasunobu Miyake, Fumika Mi‐ichi, Yoichiro Iwakura, Hiromitsu Hara, Hiroki Yoshida	5
9	Murine γ-Herpesvirus 68 Induces Severe Lung Inflammation in IL-27–Deficient Mice with Liver Dysfunction Preventable by Oral Neomycin 2018 ·The Journal of Immunology ·K Kanai, Ah-Mee Park, Akiko Watanabe, Tomohiro Arikawa, Teruhito Yasui, Hiroki Yoshida, Ikuo Tsunoda, Osamu Yoshie	5
10	IL-17A contributes to reducing IFN-γ/IL-4 ratio and persistence of Entamoeba histolytica during intestinal amebiasis 2017 ·Parasitology International ·(unknown), Risa Nakamura, Mihoko Kikuchi, (unknown), (unknown), (unknown), Masachika Senba, Yoichiro Iwakura, Hiroki Yoshida, Shinjiro Hamano	4
11	IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice 2016 ·The Journal of Immunology ·K Kanai, Ah-Mee Park, Hiroki Yoshida, Ikuo Tsunoda, Osamu Yoshie	27
12	EBI3 is pivotal for the initiation of experimental autoimmune uveitis 2014 ·Experimental Eye Research ·Atsunobu Takeda, Eiichi Hasegawa, (unknown), (unknown), Hisakata Yamada, Yang Yang, Takeru Yoshimura, Toshio Hisatomi, Yuji Oshima, Hiroki Yoshida, Koh‐Hei Sonoda, Tatsuro Ishibashi	10
13	A STUDY OF THE EMERGING NEEDS FOR IN-SERVICE TEACHER TRAINING COURSES FOR ICT INTEGRATION 2013 ·Hiroki Yoshida	0
14	Apaf-1-independent programmed cell death in mouse development 2009 ·Cell Death and Differentiation ·Akiomi Nagasaka, Kohki Kawane, Hiroki Yoshida, Shigekazu Nagata	55
15	Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism 2006 ·The Journal of Immunology ·Takeru Yoshimura, Atsunobu Takeda, Shinjiro Hamano, Yoshiyuki Miyazaki, Ichiko Kinjyo, Tatsuro Ishibashi, Akihiko Yoshimura, Hiroki Yoshida	207
16	WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation 2005 ·International Immunology ·Atsunobu Takeda, Shinjiro Hamano, Hiroshi Shiraishi, Takeru Yoshimura, Hisanobu Ogata, Kazunari Ishii, Tatsuro Ishibashi, Akihiko Yoshimura, Hiroki Yoshida	21
17	Hyperproduction of Proinflammatory Cytokines by WSX-1-Deficient NKT Cells in Concanavalin A-Induced Hepatitis 2004 ·The Journal of Immunology ·Atsushi Yamanaka, Shinjiro Hamano, Yoshiyuki Miyazaki, Kazunari Ishii, Atsunobu Takeda, Tak W. Mak, Kunisuke Himeno, Akihiko Yoshimura, Hiroki Yoshida	76
18	WSX-1: A Key Role in Induction of Chronic Intestinal Nematode Infection 2004 ·The Journal of Immunology ·Allison J. Bancroft, Neil Humphreys, John J. Worthington, Hiroki Yoshida, Richard K. Grencis	50
19	Influence of the flow rate during flushing on porcine multivisceral preservation. 1998 ·PubMed ·Teruo Komokata, Seigo Nishida, Seiji Ogata, Nobuo Hamada, Akira Ikoma, Koki Tanaka, Hiroki Yoshida, Akira Taira	4
20	An experimental and clinical study of the reinforced biosynthetic ovine collagen vascular prosthesis (Omniflow) for small vessel reconstruction 1992 ·Hiroki Yoshida	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact